Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homepr

      pr

      Embraer Delivers 11 Commercial and 21 Executive Jets in 2Q22
      Industrials

      Embraer Delivers 11 Commercial and 21 Executive Jets in 2Q22

      July 25, 2022
      Bally’s Announces Preliminary Results of Tender Offer
      Gaming

      Bally’s Announces Preliminary Results of Tender Offer

      July 25, 2022
      Kiwetinohk schedules Q2, 2022 quarterly results
      Oil & Gas

      Kiwetinohk schedules Q2, 2022 quarterly results

      July 25, 2022
      Foran Announces Agreement with Sandvik to Supply Initial Battery Electric Equipment for McIlvenna Bay
      Mining

      Foran Announces Agreement with Sandvik to Supply Initial Battery Electric Equipment for McIlvenna Bay

      July 25, 2022
      Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
      Biotech

      Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      July 22, 2022
      Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      July 22, 2022
      Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
      Biotech

      Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement

      July 22, 2022
      Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results
      Biotech

      Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results

      July 22, 2022
      Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
      Biotech

      Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

      July 22, 2022
      Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel
      Biotech

      Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel

      July 22, 2022
      « 1 … 972 973 974 975 976 … 1,017 »

       

      LATEST NEWS

      • Investing News HPE Q4 Earnings and Future Prospects
      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025